Search Results - "Lajavardi, Laure"
-
1
Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority
Published in Frontiers in pharmacology (15-08-2022)“…The COVID-19 pandemic was immediately marked by strong clinical research activity. The French national competent authority presents the data on request for…”
Get full text
Journal Article -
2
New formulation of vasoactive intestinal peptide using liposomes in hyaluronic acid gel for uveitis
Published in Journal of controlled release (01-10-2009)“…We evaluated the benefits of a novel formulation of vasoactive intestinal peptide (VIP) based on the incorporation of VIP-loaded rhodamine-conjugated liposomes…”
Get full text
Journal Article -
3
Downregulation of Endotoxin-Induced Uveitis by Intravitreal Injection of Vasoactive Intestinal Peptide Encapsulated in Liposomes
Published in Investigative ophthalmology & visual science (01-07-2007)“…To reestablish the immunosuppressive microenvironment of the eye, disrupted by ocular inflammation during endotoxin-induced uveitis (EIU), by means of…”
Get full text
Journal Article -
4
Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis
Published in The journals of gerontology. Series A, Biological sciences and medical sciences (04-07-2014)“…Insulin-like growth factor I (IGF-I) and insulin-like growth factor binding protein 3 (IGFBP-3) are involved in oxidative stress and atherosclerosis; however,…”
Get full text
Journal Article -
5
Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis
Published in Journal of ocular pharmacology and therapeutics (01-02-2009)“…The aim of this study was to investigate the effect of a single intravitreal (i.v.t.) injection of vasoactive intestinal peptide (VIP) loaded in…”
Get more information
Journal Article